BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1748 related articles for article (PubMed ID: 29805306)

  • 21. Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy.
    Hui EP; Li WF; Ma BB; Lam WKJ; Chan KCA; Mo F; Ai QYH; King AD; Wong CH; Guo R; Poon DMC; Tong M; Li L; Lau TKH; Wong KCW; Lam DCM; Lo YMD; Ma J; Chan ATC
    Ann Oncol; 2020 Jun; 31(6):769-779. PubMed ID: 32217076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma.
    Wu S; Yuan X; Huang H; Li Y; Cui L; Lin D; Lu W; Feng H; Chen Z; Liu X; Tan J; Wang F
    BMC Cancer; 2023 Dec; 23(1):1217. PubMed ID: 38066499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma.
    Wang X; Mao M; He Z; Zhang L; Li H; Lin J; He Y; Dai S; Hu W; Liu W
    Int J Biol Sci; 2019; 15(1):221-228. PubMed ID: 30662361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nomogram for predicting survival of nasopharyngeal carcinoma patients with metachronous metastasis.
    Zeng Z; Shen L; Wang Y; Shi F; Chen C; Wu M; Bai Y; Pan C; Xia Y; Wu P; Li W
    Medicine (Baltimore); 2016 Jul; 95(27):e4026. PubMed ID: 27399084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
    Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
    Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients.
    Li X; Huang H; Yu X; Chen P; Ouyang J; Huang B
    Surg Oncol; 2020 Jun; 33():51-57. PubMed ID: 32561099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II-IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort.
    Sun XS; Xiao BB; Lin C; Liu SL; Chen QY; Tang LQ; Mai HQ
    Cancer Med; 2020 Mar; 9(5):1661-1670. PubMed ID: 31925942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of a Prognostic Nomogram for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Incorporating TNM Stage, Post-Induction Chemotherapy Tumor Volume and Epstein-Barr Virus DNA Load.
    Jiang YT; Chen KH; Yang J; Liang ZG; Qu S; Li L; Zhu XD
    Front Oncol; 2021; 11():683475. PubMed ID: 34222003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel Nomogram Integrated with Inflammation-Based Factors to Predict the Prognosis of Gastric Cancer Patients.
    Wang X; Mao M; Zhu S; Xing S; Song Y; Zhang L; Chi P
    Adv Ther; 2020 Jun; 37(6):2902-2915. PubMed ID: 32363466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional lymph node density-based nomogram predicts prognosis in nasopharyngeal carcinoma patients without distant metastases.
    Ma J; Zhao R; Wu YL; Liu Y; Jin GQ; Su DK
    Cancer Imaging; 2023 Dec; 23(1):123. PubMed ID: 38102725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and Validation of a Nomogram for Predicting Survival Based on Ferritin and Transferrin Ratio in Breast Cancer Patients.
    Huang S; Lai H; Pan X; Lin Q; Qin Y; Liu F; Fang M; Huang W; Wei C
    Cancer Control; 2024; 31():10732748241261553. PubMed ID: 38850515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Nomogram Based on Aspartate Aminotransferase/Alanine Aminotransferase (AST/ALT) Ratio to Predict Prognosis After Surgery in Gastric Cancer Patients.
    Li L; Zeng Q; Xue N; Wu M; Liang Y; Xu Q; Feng L; Xing S; Chen S
    Cancer Control; 2020; 27(1):1073274820954458. PubMed ID: 32959672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
    Pan JJ; Ng WT; Zong JF; Lee SW; Choi HC; Chan LL; Lin SJ; Guo QJ; Sze HC; Chen YB; Xiao YP; Kan WK; O'Sullivan B; Xu W; Le QT; Glastonbury CM; Colevas AD; Weber RS; Lydiatt W; Shah JP; Lee AW
    Cancer; 2016 Nov; 122(21):3307-3315. PubMed ID: 27434142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic nomogram integrated systemic inflammation score for patients with esophageal squamous cell carcinoma undergoing radical esophagectomy.
    Shao Y; Ning Z; Chen J; Geng Y; Gu W; Huang J; Pei H; Shen Y; Jiang J
    Sci Rep; 2015 Dec; 5():18811. PubMed ID: 26689680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and Validation of Web-Based Nomograms to Precisely Predict Survival Outcomes of Non-metastatic Nasopharyngeal Carcinoma in an Endemic Area.
    Yao JJ; Lin L; Gao TS; Zhang WJ; Lawrence WR; Ma J; Sun Y
    Cancer Res Treat; 2021 Jul; 53(3):657-670. PubMed ID: 33285052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of a prognostic scoring model for regional recurrent nasopharyngeal carcinoma after neck dissection.
    Li X; Lin C; Yan J; Chen Q; Sun X; Liu S; Guo S; Liu L; Xie H; Tang Q; Liang Y; Guo L; Li H; Liu X; Guo X; Tang L; Mai H
    Cancer Biol Med; 2020 Feb; 17(1):227-236. PubMed ID: 32296590
    [No Abstract]   [Full Text] [Related]  

  • 37. MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it.
    Li WZ; Liu GY; Lin LF; Lv SH; Qiang MY; Lv X; Wu YS; Liang H; Ke LR; Wang DL; Yu YH; Qiu WZ; Liu KY; Guo X; Li JP; Zou YJ; Xiang YQ; Xia WX
    Radiother Oncol; 2020 Apr; 145():101-108. PubMed ID: 31931288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of Pre-Treatment CALLY Score Combined with EBV-DNA Levels for Prognostication in Non-Metastatic Nasopharyngeal Cancer Patients: A Clinical Perspective.
    Jiang T; Sun H; Xu T; Xue S; Xia W; Xiao X; Wang Y; Guo L; Lin H
    J Inflamm Res; 2024; 17():3353-3369. PubMed ID: 38803689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-sensitivity C-reactive protein complements plasma Epstein-Barr virus deoxyribonucleic acid prognostication in nasopharyngeal carcinoma: a large-scale retrospective and prospective cohort study.
    Tang LQ; Li CF; Chen QY; Zhang L; Lai XP; He Y; Xu YX; Hu DP; Wen SH; Peng YT; Chen WH; Liu H; Guo SS; Liu LT; Li J; Zhang JP; Guo L; Zhao C; Cao KJ; Qian CN; Zeng YX; Guo X; Mai HQ; Zeng MS
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):325-36. PubMed ID: 25482300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.
    Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y
    Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 88.